Global Announcement Would Go Here With LINK

All Tests, Immunity & Infectious Disease, COVID-19

Covid-19 Antibody Test-Insurance

$ 0.0
$0 - $49.00

Get a combination PCR home collection kit to find out if you have COVID-19, flu, or RSV all with one swab.

Covid-19 Antibody Test-Insurance
$ 0.0
$0 - $49.00

Test Details

Sample Type: Nasal Swab
Collection Method: Home collection. Mail sample to lab for results
Age: 2+
Results: 1-2 days from when your sample arrives at our lab
HSA/FSA: Accepted

Preparation: No special preparation is needed. 

Confidence in your results, with the gold standard PCR test

What's in Your Kit?

Your at-home collection kit comes with everything you need to collect your sample and send it back to our lab. 

Woman opens collection kit.

The test trusted by millions of people for COVID-19 answers

95% of customers find ordering and collecting the sample easy.

  • We have been regularly tracking variants of the virus throughout the pandemic to provide information to the CDC. The sensitivity of our PCR test is not impacted by the following known variants.
     

    • Alpha (B.1.1.7, Q.1-Q.8)
    • Beta (B.1.351, B.1.351.2, B.1.351.3)
    • Delta (B.1.617.2) 
    • Gamma (P.1, P.1.1, P.1.2)
    • Lambda (C.37)
    • Mu (B.1.621)
    • Omicron (B.1.1.529, BA.2, BA.4, BA.5, BQ variants) 
    • Zeta (P.2)
       

    *The variant information will not be included in your results report. For a full list of variants detected by the Labcorp PCR test, visit Labcorp.com.

  • The Pixel by Labcorp® COVID-19 + Flu + RSV at-home kit is a PCR test, also known as a reverse polymerase chain reaction test or a nucleic acid amplification test (NAAT). This test detects the presence or absence of SARS-CoV-2, the virus that causes COVID-19, as well as influenza A or B, and Respiratory Syncytial Virus (RSV).

  • This collection kit is $129 and intended for individuals ages 2 or older looking to get tested for an active infection.

  • Your test results will detect whether you are infected with SARS-CoV-2, Influenza A, Influenza B and/or RSV. If your results are positive for one or more of the viruses, it is important to limit your exposure to other people and continue to monitor your symptoms. If your results are negative, the viruses were not detected in the sample you provided. However, it is important to note that the viruses may not be detected by the test in early stages of infection. Furthermore, the viruses may not be detected if the sample is not collected as directed. If you have reason to believe you have been exposed, it is important to follow up with a healthcare provider for further evaluation, get re-tested, and follow isolation or quarantine precautions as recommended.
     

    After receiving your results, you will have the opportunity to speak with a licensed healthcare provider who can answer any questions you may have about your test results and help determine next steps in care.

     

  • If you feel like you are having a medical emergency, please call 9-1-1.
     

    If you are experiencing severe trouble breathing; continuous pain or pressure in your chest or abdomen; feeling confused; having difficulty waking up or staying awake; pale, gray, or blue-colored skin, lips, or nail beds; seizures; being unable to urinate; severe muscle pain or weakness; fever or cough that improves but then returns or worsens; worsening of medical conditions; or any other emergency signs or symptoms, please seek immediate medical care.


    If your condition changes before you are able to obtain the test or the test result, please visit your local emergency room as soon as possible.

     

  • The federal Public Health Emergency (PHE) for COVID-19 which was declared under Section 319 of the Public Health Service Act, is ending at the end of the day on May 11, 2023.

     

    Following changes to the public health emergency, the requirements for how commercial insurers must cover COVID-19 tests will change.  Likewise, there are changes to requirements for government programs for coverage of this testing.

     

    Individuals will be responsible for the full cost of COVID-19 testing at the time of purchase effective on May 12, 2023.

     

    If you submit your test to Labcorp after May 11, 2023, and are relying on commercial insurance or a government program benefit to pay for COVID-19 testing, you may be responsible for payment for the test in accordance with their new coverage policies.  To learn more about your coverage, please check with your insurance company or government program on their policy.

     

    A separate COVID-19 PHE will remain in effect, allowing tests and other products, including vaccines, to continue to be offered. A termination date for that PHE has not yet been announced.   

     

    See Public Health Emergency Expiration FAQs for more information.